Table 7 Correlation between sADO with sPD-L1, sPD-1, and the other studied parameters among the B-NHL patients’ group.
From: Illuminating the impact of CD38-induced adenosine formation in B-cell lymphoma
sADO | sPD-L1 | sPD-1 | ||||
|---|---|---|---|---|---|---|
r | p | r | p | r | p | |
sPD-L1 (ng/L) | 0.116 | 0.465 | 0.312* | 0.044 | ||
sPD-1 (ng/L) | 0.324* | 0.037 | 0.312* | 0.044 | ||
sADO (ng/ml) | 0.116 | 0.465 | 0.324* | 0.037 | ||
Age (years) | − 0.128 | 0.418 | 0.079 | 0.619 | − 0.088 | 0.581 |
WBC (x103/ul) | − 0.212 | 0.178 | − 0.213 | 0.175 | − 0.204 | 0.195 |
LYMPH (x103/ul) | − 0.240 | 0.126 | − 0.253 | 0.106 | − 0.259 | 0.098 |
HB (g/dl) | − 0.223 | 0.155 | 0.165 | 0.297 | − 0.102 | 0.519 |
PLT (x103/ul) | − 0.490** | 0.001 | 0.058 | 0.714 | − 0.171 | 0.280 |
BM.LYM (%) | 0.301 | 0.053 | − 0.082 | 0.606 | − 0.039 | 0.808 |
